Endocrine therapy for breast cancer can exacerbate menopausal symptoms. The association between endocrine therapy and common pelvic floor disorders including urinary incontinence has rarely been evaluated. We examined urogenital and sexual side effects among women with a breast cancer diagnosis, comparing endocrine therapy users to nonusers
Introduction. Women with breast cancer have better cancer-related outcomes with the use of aromatase...
OBJECTIVE: The aim of the study was to determine the association between adjuvant chemotherapy for b...
Clinical trials of adjuvant endocrine therapy in women with early breast cancer have consistently re...
Endocrine therapy (ET) for hormone receptor-positive (HR+) breast cancer can contribute to gynecolog...
There is increasing attention and concern about managing the adverse effects of adjuvant endocrine t...
There is increasing attention and concern about managing the adverse effects of adjuvant endocrine t...
The underlying hypothesis of this PhD is that the negative impact of adjuvant endocrine therapy on g...
Importance: Genitourinary syndrome of menopause can be treated with vaginal estrogen therapy. Howeve...
BackgroundAs the number of breast cancer survivors increases, the long term consequences of breast c...
Objectives To evaluate (a) the prevalence of genitourinary symptoms, (b) which demographic and clin...
AbstractIntroductionWomen with breast cancer have better cancer‐related outcomes with the use of aro...
Many hormonal modalities are available for breast cancer treatment, such as selective oestrogen rece...
Postmenopausal women should not receive oral hormone therapy for treatment of urinary incontinence. ...
Breast cancer is one of the main life-threatening diseases that a woman may have to face during her ...
Introduction Women affected by breast cancer (BC) will often go through menopause at an earlier age ...
Introduction. Women with breast cancer have better cancer-related outcomes with the use of aromatase...
OBJECTIVE: The aim of the study was to determine the association between adjuvant chemotherapy for b...
Clinical trials of adjuvant endocrine therapy in women with early breast cancer have consistently re...
Endocrine therapy (ET) for hormone receptor-positive (HR+) breast cancer can contribute to gynecolog...
There is increasing attention and concern about managing the adverse effects of adjuvant endocrine t...
There is increasing attention and concern about managing the adverse effects of adjuvant endocrine t...
The underlying hypothesis of this PhD is that the negative impact of adjuvant endocrine therapy on g...
Importance: Genitourinary syndrome of menopause can be treated with vaginal estrogen therapy. Howeve...
BackgroundAs the number of breast cancer survivors increases, the long term consequences of breast c...
Objectives To evaluate (a) the prevalence of genitourinary symptoms, (b) which demographic and clin...
AbstractIntroductionWomen with breast cancer have better cancer‐related outcomes with the use of aro...
Many hormonal modalities are available for breast cancer treatment, such as selective oestrogen rece...
Postmenopausal women should not receive oral hormone therapy for treatment of urinary incontinence. ...
Breast cancer is one of the main life-threatening diseases that a woman may have to face during her ...
Introduction Women affected by breast cancer (BC) will often go through menopause at an earlier age ...
Introduction. Women with breast cancer have better cancer-related outcomes with the use of aromatase...
OBJECTIVE: The aim of the study was to determine the association between adjuvant chemotherapy for b...
Clinical trials of adjuvant endocrine therapy in women with early breast cancer have consistently re...